Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude+Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Globus Medical, Inc. Class A Common Stock
(NY:
GMED
)
76.64
-0.57 (-0.74%)
Official Closing Price
Updated: 7:00 PM EDT, May 15, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Globus Medical, Inc. Class A Common Stock
< Previous
1
2
3
4
5
6
7
8
9
...
13
14
Next >
5 Must-Read Analyst Questions From Globus Medical’s Q1 Earnings Call
May 14, 2026
Globus Medical’s first quarter delivered results ahead of Wall Street’s expectations, but the market reacted negatively, with shares declining over 5%. Manag...
Via
StockStory
Topics
Earnings
Economy
Globus Medical Inc - A (NYSE:GMED) Screens as a Top-Tier Quality Growth Stock on the Caviar Cruise Investment Model
↗
May 12, 2026
Via
Chartmill
Global Alpha Dumps 229,000 Ani Pharmaceuticals (ANIP) Shares Worth $17.9 Million
↗
May 11, 2026
ANI Pharmaceuticals develops and manufactures branded and generic drugs for diverse North American healthcare markets.
Via
The Motley Fool
1 Healthcare Stock with Competitive Advantages and 2 We Brush Off
May 11, 2026
From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes. But speed bumps such as inventory de...
Via
StockStory
Globus Medical (NYSE:GMED) Delivers Massive Q1 Beat, Guides EPS Higher
↗
May 07, 2026
Via
Chartmill
Globus Medical Inc - A (NYSE:GMED) Fits the Affordable Growth Profile
↗
April 30, 2026
Via
Chartmill
Globus Medical Inc - A (NYSE:GMED) Scores High Growth Momentum and Technical Setup Ratings
↗
April 22, 2026
Via
Chartmill
Globus Medical Q1 Earnings Call Highlights
↗
May 10, 2026
Globus Medical (NYSE:GMED) reported a strong start to 2026, with first-quarter revenue and earnings rising sharply as the company cited continued momentum in U.S. spine, margin expansion and...
Via
MarketBeat
Topics
Earnings
GMED Q1 Deep Dive: Margin Expansion and Strategy Shift Amid Market Share Gains
May 08, 2026
Medical device company Globus Medical (NYSE:GMED) announced better-than-expected revenue in Q1 CY2026, with sales up 27% year on year to $759.9 million. The ...
Via
StockStory
Topics
Economy
Globus Medical (GMED) Q1 2026 Earnings Transcript
↗
May 07, 2026
Globus Medical (GMED) Q1 2026 Earnings Transcript
Via
The Motley Fool
Globus Medical Inc (NYSE:GMED): A Prime Affordable Growth Stock with Strong Fundamentals
↗
April 01, 2026
Via
Chartmill
Globus Medical Inc. (NYSE:GMED) Presents a Compelling Mix of Strong Fundamentals and Technical Setup
↗
March 24, 2026
Via
Chartmill
Globus Medical Inc (NYSE:GMED): A GARP Stock with Strong Growth and a Reasonable Price
↗
March 09, 2026
Via
Chartmill
Globus Medical Inc (NYSE:GMED) Beats Q4 Estimates and Raises 2026 EPS Guidance
↗
February 24, 2026
Via
Chartmill
Globus Medical’s (NYSE:GMED) Q1 CY2026: Beats On Revenue
May 07, 2026
Medical device company Globus Medical (NYSE:GMED) beat Wall Street’s revenue expectations in Q1 CY2026, with sales up 27% year on year to $759.9 million. The...
Via
StockStory
Globus Medical Reports First Quarter 2026 Results
May 07, 2026
From
Globus Medical
Via
GlobeNewswire
Globus Medical (GMED) Reports Q1: Everything You Need To Know Ahead Of Earnings
May 05, 2026
Medical device company Globus Medical (NYSE:GMED) will be reporting earnings this Thursday afternoon. Here’s what you need to know. Globus Medical beat analy...
Via
StockStory
Medical Devices & Supplies - Specialty Q4 Earnings: Globus Medical (NYSE:GMED) is the Best in the Biz
April 26, 2026
The end of the earnings season is always a good time to take a step back and see who shined (and who not so much). Let’s take a look at how medical devices &...
Via
StockStory
2 Cash-Heavy Stocks with Exciting Potential and 1 We Turn Down
April 17, 2026
A surplus of cash can mean financial stability, but it can also indicate a reluctance (or inability) to invest in growth. Some of these companies also face c...
Via
StockStory
Globus Medical Schedules First Quarter Earnings Release and Conference Call
April 16, 2026
From
Globus Medical
Via
GlobeNewswire
2 Reasons to Like GMED and 1 to Stay Skeptical
April 15, 2026
What a fantastic six months it’s been for Globus Medical. Shares of the company have skyrocketed 62.5%, hitting $94.80. This was partly thanks to its solid q...
Via
StockStory
2 Profitable Stocks with Promising Prospects and 1 Facing Challenges
April 08, 2026
Even if a company is profitable, it doesn’t always mean it’s a great investment. Some struggle to maintain growth, face looming threats, or fail to reinvest ...
Via
StockStory
Is Stagflation Creeping Into the Picture?
↗
March 29, 2026
GDP data shows an economy that slowed to a crawl in the fourth quarter of 2025 as inflation picked up.
Via
The Motley Fool
Topics
Economy
Stocks
World Trade
Artivion, Intuitive Surgical, GE HealthCare, LeMaitre, and Globus Medical Shares Plummet, What You Need To Know
March 27, 2026
What Happened? A number of stocks fell in the afternoon session after major indices including the S&P 500 and Dow Jones Industrial Average fell sharply as in...
Via
StockStory
Topics
Government
Stocks
Globus Medical Announces Board Departure
March 23, 2026
From
Globus Medical
Via
GlobeNewswire
1 Cash-Producing Stock to Target This Week and 2 That Underwhelm
March 17, 2026
Generating cash is essential for any business, but not all cash-rich companies are great investments. Some produce plenty of cash but fail to allocate it eff...
Via
StockStory
This Investor Sold $104 Million of Nuvalent Stock Amid Cancer Drug Developer's Nearly 30% Rally
↗
March 16, 2026
Nuvalent develops targeted therapies for drug-resistant cancers, advancing clinical-stage candidates in precision oncology.
Via
The Motley Fool
This Biotech Attracted a $181 Million Investment During a Staggering 1,300% Stock Rally
↗
March 16, 2026
This clinical-stage biotech develops small-molecule therapies targeting NASH, obesity, and related metabolic diseases.
Via
The Motley Fool
2 Growth Stocks to Stash and 1 We Turn Down
March 12, 2026
Growth boosts valuation multiples, but it doesn’t always last forever. Companies that cannot maintain it are often penalized with large declines in market va...
Via
StockStory
Topics
Economy
3 Healthcare Stocks to Target This Week
March 09, 2026
Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. Shareholders who bet on the industry have se...
Via
StockStory
< Previous
1
2
3
4
5
6
7
8
9
...
13
14
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.